share_log

LexaGene Holdings Inc. (OTCMKTS:LXXGF) Sees Significant Decline in Short Interest

LexaGene Holdings Inc. (OTCMKTS:LXXGF) Sees Significant Decline in Short Interest

利盟基因控股公司(场外交易代码:LXXGF)认为空头股数的市场份额大幅下降
kopsource ·  2022/10/01 00:42

LexaGene Holdings Inc. (OTCMKTS:LXXGF – Get Rating) saw a large decrease in short interest in the month of September. As of September 15th, there was short interest totalling 99,700 shares, a decrease of 23.1% from the August 31st total of 129,600 shares. Based on an average daily trading volume, of 82,200 shares, the short-interest ratio is presently 1.2 days.

利盟基因控股有限公司(场外交易代码:LXXGF-GET Rating)在9月份看到空头股数的销售额大幅下降。截至9月15日,空头股数共有99,700股,比8月31日的129,600股减少了23.1%。以日均成交量八万二千二百股计算,目前短息比率为一点二天。

LexaGene Stock Performance

Lexagene股票表现

OTCMKTS:LXXGF traded up 0.00 during midday trading on Friday, hitting 0.10. 7,000 shares of the company traded hands, compared to its average volume of 120,557. The firm's fifty day moving average is 0.11 and its 200-day moving average is 0.14. LexaGene has a 12-month low of 0.08 and a 12-month high of 0.48.

OTCMKTS:LXXGF在周五午盘交易中上涨0.00,触及0.10。该公司有7000股易手,而其平均成交量为120,557股。该公司的50日移动均线切入位在0.11,200日移动均线切入位在0.14。Lexagene的12个月低点为0.08,12个月高位为0.48。

Get
到达
LexaGene
Lexagene
alerts:
警报:

About LexaGene

关于Lexagene

(Get Rating)

(获取评级)

LexaGene Holdings Inc, a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets.
Lexagene控股公司是一家生物技术公司,从事病原体检测系统的研究、开发和商业化。它提供MiQLab,这是一种自动病原体检测系统,旨在改变兽医诊断、人类临床诊断、食品和水安全测试以及其他生命科学市场中的病原体检测。

Further Reading

进一步阅读

  • Get a free copy of the StockNews.com research report on LexaGene (LXXGF)
  • This Is A Memorable Time To Buy Into Micron Technology
  • Let Paychex Stock Work Hard For You
  • Thor Industries Hammers Out A Bottom
  • Declining Profits Challenge the CarMax Value Proposition
  • How Does Keurig Dr Pepper Compare To Larger Rivals Coke & Pepsi?
  • 免费获取StockNews.com关于Lexagene的研究报告(LXXGF)
  • 这是买入美光科技的难忘时刻
  • 让Paychex股票为您努力工作
  • 雷神工业走出谷底
  • 利润下降对CarMax价值主张的挑战
  • Keurig Dr Pepper与规模更大的竞争对手可口可乐(Coke&Pepsi)相比如何?

Receive News & Ratings for LexaGene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LexaGene and related companies with MarketBeat.com's FREE daily email newsletter.

接受Lexagene日报的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Lexagene和相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发